| Autor: |
Oliveira NPD; Departamento de Fisioterapia, Universidade de Pernambuco. BR 203 Km 2 s/n, Vila Eduardo. 56328903 Petrolina PE Brasil. nayara.oliveira@upe.br., Cancela MC; Divisão de Vigilância e Análise de Situação, Instituto Nacional de Câncer, Ministério da Saúde. Rio de Janeiro RJ Brasil., Martins LFL; Divisão de Vigilância e Análise de Situação, Instituto Nacional de Câncer, Ministério da Saúde. Rio de Janeiro RJ Brasil., Castro JL; Programa de Pós-Graduação em Saúde Coletiva, Departamento de Saúde Coletiva, Universidade Federal do Rio Grande do Norte. Natal RN Brasil., Meira KC; Programa de Pós-Graduação em Demografia, Escola de Saúde, Universidade Federal do Rio Grande do Norte. Natal RN Brasil., Souza DLB; Programa de Pós-Graduação em Saúde Coletiva, Departamento de Saúde Coletiva, Universidade Federal do Rio Grande do Norte. Natal RN Brasil. |
| Jazyk: |
portugalština |
| Zdroj: |
Ciencia & saude coletiva [Cien Saude Colet] 2024 Jun; Vol. 29 (6), pp. e03872023. Date of Electronic Publication: 2023 Aug 10. |
| DOI: |
10.1590/1413-81232024296.03872023 |
| Abstrakt: |
The scope of this study is to analyze the prevalence of advanced stage diagnosis of cervical cancer and its association with individual and contextual socioeconomic and healthcare service indicators in Brazil. A cross-sectional study was conducted using cervical cancer cases in women aged 18 to 99 years, from 2006 to 2015, extracted from the Hospital Cancer Registry (HCR) Integrator. Contextual variables were collected from the Atlas of Human Development in Brazil; the National Registry of Health Institutions (NRHI); and the Outpatient Information System. Multilevel Poisson Regression with random intercept was used. The prevalence of advanced stage diagnosis was 48.4%, revealing an association with older age groups (PR 1.06; CI 1.01-1.10), black, brown, and indigenous race/skin color (PR 1.04; CI 1.01-1.07), lower levels of schooling (PR 1.28; CI 1.16-1.40), no marital partner (PR 1.10; CI 1.07-1.13), public referral to the health service (PR 1.07; CI 1.03-1.11), and lower rates of cytological examination (PR 1.08; CI 1.01-1.14). The results reinforce the need for improvements in the national cervical cancer prevention program in areas with low coverage of oncotic cytology. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
